Acorda Therapeutics reported $11M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Acorda Therapeutics ACOR:US USD 11M 2.2M
Agios Pharmaceuticals AGIO:US USD 517K 82K
Amgen AMGN:US USD 1.59B 78M
Anika Therapeutics ANIK:US USD 17.48M 2.69M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Cara Therapeutics CARA:US USD 3.06M 3.06M
Clovis Oncology CLVS:US USD 8.61M 607K
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Halozyme Therapeutics HALO:US USD 47.32M 13.38M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Insmed INSM:US USD 13.47M 2.92M
Ligand Pharmaceuticals LGND:US USD 14.15M 1.79M
Mannkind MNKD:US USD 17.46M 4.54M
Merck MRK:GR EUR 2.15B 38M
Moderna Inc MRNA:US USD 1.1B 281M
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Novartis NOVN:VX USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Ultragenyx Pharmaceutical RARE:US USD 8.63M 361K
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M